Dual inhibition of EZH2 and ATM displays synergistic cytotoxicity in BRCA1-deficient breast

被引：0
|
作者：
Puppe, J. [1 ]
Brambillasca, C. [2 ]
Ratz, L. [3 ]
Bartke, L. [3 ]
van de Ven, M. [2 ]
Bouwman, P. [2 ]
van Tellingen, O. [2 ]
Isensee, J. [4 ]
Hucho, T. [4 ]
van Lohuizen, M. [2 ]
Malter, W. [3 ]
Schmutzler, R. [5 ]
Mallmann, P. [3 ]
Jonkers, J. [2 ]
Reinhardt, C. [6 ]
机构：
[1] Uniklin Koln, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Cologne, Germany
[2] Netherlands Canc Inst, Amsterdam, Netherlands
[3] Uniklin Koln, Klin & Poliklin Frauenheilkunde, Cologne, Germany
[4] Uniklin Koln, Cologne, Germany
[5] Uniklin Koln, Zentrum Familiarer Brust & Eierstockkrebs, Cologne, Germany
[6] Uniklin Koln, Innere Med Klin 1, Cologne, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2020年 / 80卷 / 10期
关键词：
D O I：
10.1055/s-0040-1717869
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P037
引用
收藏
页码：E104 / E104
页数：1
相关论文
共 50 条
  • [1] Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
    Ratz, Leonie
    Brambillasca, Chiara
    Bartke, Leandra
    Huetzen, Maxim A.
    Goergens, Jonas
    Leidecker, Orsolya
    Jachimowicz, Ron D.
    van de Ven, Marieke
    Proost, Natalie
    Siteur, Bjorn
    de Korte-Grimmerink, Renske
    Bouwman, Peter
    Pulver, Emilia M.
    de Bruijn, Roebi
    Isensee, Joerg
    Hucho, Tim
    Pandey, Gaurav
    van Lohuizen, Maarten
    Mallmann, Peter
    Reinhardt, Hans Christian
    Jonkers, Jos
    Puppe, Julian
    BREAST CANCER RESEARCH, 2022, 24 (01)
  • [2] Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
    Leonie Ratz
    Chiara Brambillasca
    Leandra Bartke
    Maxim A. Huetzen
    Jonas Goergens
    Orsolya Leidecker
    Ron D. Jachimowicz
    Marieke van de Ven
    Natalie Proost
    Bjørn Siteur
    Renske de Korte-Grimmerink
    Peter Bouwman
    Emilia M. Pulver
    Roebi de Bruijn
    Jörg Isensee
    Tim Hucho
    Gaurav Pandey
    Maarten van Lohuizen
    Peter Mallmann
    Hans Christian Reinhardt
    Jos Jonkers
    Julian Puppe
    Breast Cancer Research, 24
  • [3] Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
    Ratz, L.
    Brambillasca, C.
    Bartke, L.
    Huetzen, M.
    Goergens, J.
    Leidecker, O.
    Jachimowicz, R.
    van de Ven, M.
    Proost, N.
    Siteur, B.
    de Korte-Grimmerink, R.
    Bouwman, P.
    Pulver, E. M.
    de Bruijn, R.
    Isensee, J.
    Hucho, T.
    Pandey, G.
    van Lohuizen, M.
    Mallmann, P.
    Reinhardt, H. C.
    Jonkers, J.
    Puppe, J.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E146 - E146
  • [4] Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma
    Landman, Nick
    Hulsman, Danielle
    Badhai, Jitendra
    Kopparam, Jawahar
    Puppe, Julian
    Pandey, Gaurav Kumar
    van Lohuizen, Maarten
    BRITISH JOURNAL OF CANCER, 2024, 130 (11) : 1855 - 1865
  • [5] Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma
    Badhai, Jitendra
    Landman, Nick
    Pandey, Gaurav Kumar
    Song, Ji-Ying
    Hulsman, Danielle
    Krijgsman, Oscar
    Chandrasekaran, Gayathri
    Berns, Anton
    van Lohuizen, Maarten
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (01): : 18 - 27
  • [6] Getting to the Root of BRCA1-Deficient Breast Cancer
    Ginestier, Christophe
    Liu, Suling
    Wicha, Max S.
    CELL STEM CELL, 2009, 5 (03) : 229 - 230
  • [7] BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
    Puppe, Julian
    Drost, Rinske
    Liu, Xiaoling
    Joosse, Simon A.
    Evers, Bastiaan
    Cornelissen-Steijger, Paulien
    Nederlof, Petra
    Yu, Qiang
    Jonkers, Jos
    van Lohuizen, Maarten
    Pietersen, Alexandra M.
    BREAST CANCER RESEARCH, 2009, 11 (04)
  • [8] BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
    Julian Puppe
    Rinske Drost
    Xiaoling Liu
    Simon A Joosse
    Bastiaan Evers
    Paulien Cornelissen-Steijger
    Petra Nederlof
    Qiang Yu
    Jos Jonkers
    Maarten van Lohuizen
    Alexandra M Pietersen
    Breast Cancer Research, 11
  • [9] The claudin expression signature of BRCA1-deficient breast cancer.
    van Voss, Marise R. Heerma
    van der Groep, Petra
    Smolders, Yvonne H. C.
    Bart, Joost
    Van der Wall, Elsken
    van Diest, Paul J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] The role of Pin1 in chemosensitivity of BRCA1-deficient breast cancers
    Knowlson, Catherine
    Mullan, Paul
    Buckley, Niamh
    CANCER RESEARCH, 2017, 77
12345